EGFR and neoplasm: Yet, the combination of radiotherapy with the epidermal growth factor receptor (EGFR) binding antibody cetuximab has shown efficacy and EGFR expression has been associated with poor survival, preferentially in non-accelerated schedules arguing for a role in tumor repopulation (37–40).